Institutional Ownership Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS). We have compiled data on the 174 institutions that hold shares in the stock, with a total of 30.3 Million shares, which have been reported (via 13F filing form) to have a value of $512 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,513,244
shares
|
$42.8 Million
0.0% of portfolio
|
Q2 2024
Added 16.03%
|
|
|
Alkeon Capital Management LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
1,897,601
shares
|
$32.3 Million
0.19% of portfolio
|
Q3 2024
Added 18.68%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
1,856,418
shares
|
$31.6 Million
0.0% of portfolio
|
Q3 2024
Added 5.65%
|
|
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
Nov 14, 2024 Q3 2024 |
1,523,732
shares
|
$25.9 Million
7.2% of portfolio
|
Q3 2024
Reduced 0.14%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,514,505
shares
|
$25.8 Million
0.01% of portfolio
|
Q3 2024
Added 27.49%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,113,590
shares
|
$19 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.82%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,018,734
shares
|
$17.3 Million
1.39% of portfolio
|
Q3 2024
Reduced 19.7%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
947,570
shares
|
$16.1 Million
0.15% of portfolio
|
Q3 2024
Added 155.86%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
879,344
shares
|
$15 Million
6.62% of portfolio
|
Q1 2024
New holding
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
866,737
shares
|
$14.8 Million
0.37% of portfolio
|
Q3 2024
Reduced 3.6%
|
|
|
Holocene Advisors, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
843,110
shares
|
$14.4 Million
0.21% of portfolio
|
Q3 2024
Added 22.49%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
763,548
shares
|
$13 Million
0.4% of portfolio
|
Q3 2024
Reduced 1.58%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
725,621
shares
|
$12.4 Million
0.0% of portfolio
|
Q3 2024
Added 6.77%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2024 Q3 2024 |
707,240
shares
|
$12 Million
1.16% of portfolio
|
Q3 2024
Reduced 27.99%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
704,923
shares
|
$12 Million
0.01% of portfolio
|
Q3 2024
Added 71.73%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
572,990
shares
|
$9.76 Million
0.02% of portfolio
|
Q3 2024
Added 45.82%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
552,506
shares
|
$9.41 Million
2.1% of portfolio
|
Q1 2024
New holding
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
525,037
shares
|
$8.94 Million
1.1% of portfolio
|
Q3 2024
New holding
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
445,068
shares
|
$7.58 Million
4.2% of portfolio
|
Q3 2024
Reduced 18.92%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
421,782
shares
|
$7.18 Million
3.46% of portfolio
|
Q3 2024
Added 112.35%
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
407,633
shares
|
$6.94 Million
6.41% of portfolio
|
Q3 2023
Added 1.37%
|
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2024 Q3 2024 |
395,276
shares
|
$6.73 Million
4.19% of portfolio
|
Q3 2024
Added 7.56%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Nov 14, 2024 Q3 2024 |
381,659
shares
|
$6.5 Million
1.32% of portfolio
|
Q3 2024
Added 0.75%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
380,000
shares
|
$6.47 Million
0.39% of portfolio
|
Q3 2024
Reduced 23.88%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
365,297
shares
|
$6.22 Million
0.0% of portfolio
|
Q3 2024
Added 8.83%
|